Try our Advanced Search for more refined results
Health
-
July 29, 2024
Delaware Hospital Sues State Over 'Unconstitutional' New Law
The largest hospital system and healthcare provider in Delaware sued the state's governor and other officials in Delaware's Court of Chancery Monday, asserting that newly enacted legislation enabling a government-appointed board to review hospital costs is unconstitutional and should be struck down.
-
July 29, 2024
Insurer Must Pay Defamation Defense Costs, Co. Says
An online health services company told a California federal court that a Hanover Insurance unit must help cover the "tens of millions of dollars" the company incurred while litigating an underlying defamation counterclaim and pursuing its own affirmative claims, calling the defense counsel the insurer installed "woefully inadequate."
-
July 29, 2024
Medical Co. Fights To Reboot Arbitration Bid At 9th Circ.
A private-equity owned medical product maker urged the Ninth Circuit on Monday to reverse a finding that a truck loader's proposed class wage claims are exempt from federal arbitration law, arguing that the court erred in finding that she engaged in interstate commerce based on "super flimsy evidence" and is exempt.
-
July 29, 2024
Boehringer Appeals HHS Win In Medicare Drug Price Suit
Boehringer Ingelheim Pharmaceuticals Inc. notified a Connecticut federal court Friday that it will appeal its loss in a lawsuit challenging a new Medicare drug price negotiation program on the grounds that it unlawfully compels the pharmaceutical giant to declare prices "fair," takes its property and imposes an excessive fine.
-
July 29, 2024
Kirkland-Led Amulet Closes $1.2B Health-Focused Fund
Kirkland & Ellis LLP-advised private equity shop Amulet Capital Partners LP on Monday announced that it successfully closed its third healthcare-focused private equity fund with roughly $1.2 billion in tow.
-
July 29, 2024
Cardiologist Hits Mass. Hospital With Equal Pay Suit
A cardiologist at Boston's Brigham and Women's Hospital says a less experienced male colleague whom she helped train is being paid $95,000 more, in violation of the Massachusetts Equal Pay Act, according to a lawsuit filed in state court.
-
July 29, 2024
$13.4M Death Verdict Appeal Voids Insurer Suit, Hanover Says
An 81-year-old woman who won a $13.4 million judgment against a group home where her son died in 2016 is asking the full Connecticut Appellate Court to overturn a panel's decision that allowed the defendant to appeal, while Hanover Insurance Co. said that a related lawsuit seeking to collect the judgment should be thrown out.
-
July 29, 2024
Ga. Health Providers Hit With Data Breach Class Action
Two Southeastern healthcare providers have been hit with a putative class action stemming from a 2023 cyberattack that allegedly compromised the information of more than 32,000 people, arguing the providers were asleep at the wheel as their patients' data was pilfered.
-
July 29, 2024
Rising Star: Hogan Lovells' Michael Snow
Michael Snow of Hogan Lovells was co-lead counsel representing Kaiser Foundation Hospitals for the launch of its value-based healthcare platform Risant Health, helped the large hospital system acquire the $10 billion Geisinger Health, and represents Oregon Health & Science University in acquiring health system Legacy Health, earning him a spot among healthcare law practitioners under age 40 honored by Law360 as Rising Stars.
-
July 26, 2024
Apple Commits To White House Guidelines For Responsible AI
Apple Inc. has signed onto the Biden administration's voluntary guidelines for "responsible" artificial intelligence innovation, joining the likes of Amazon.com Inc., Google LLC, Microsoft Corp. and a dozen other leading tech companies, the White House announced Friday.
-
July 26, 2024
Product Liability Cases To Watch 2024: A Midyear Report
Litigation over claims that social media addict children and harm mental health continues to hold attorneys' attention, along with claims that "forever chemicals" are a source of cancer.
-
July 26, 2024
Abbott Owes $495M In Baby Formula Bellwether Trial
A Missouri jury awarded $95 million in compensatory damages and $400 million in punitive damages Friday over bellwether claims that Abbott Laboratories' baby formula caused a premature baby to suffer a fully disabling condition.
-
July 26, 2024
Fla. Top Court Petitioned To Review 'Misleading' Abortion Info
A Florida coalition petitioned the state's high court to review a proposed financial impact statement that officials attached to an upcoming ballot measure legalizing abortions up to 24 weeks of pregnancy, saying the language is misleading and shouldn't be used to manipulate voters one way or the other.
-
July 26, 2024
Ohio Jury Must Consider Brain Injury Patient's Mental State
An Ohio appeals court has reinstated a suit accusing doctors of causing a man's catastrophic brain injury due to medical negligence, saying it should be up to a jury to decide whether the applicable filing deadlines can be tolled due to the man's purported mental incompetence.
-
July 26, 2024
'Worthless' Insurance Scam Gets Telemarketing CEO 25 Years
An Illinois federal judge has sentenced the owner of a telemarketing company to 25 years in federal prison for scheming with another former executive to sell consumers health insurance plans with low coverage caps.
-
July 26, 2024
Judge Allows Emotional Damages In Deaf Patient's Bias Suit
A Michigan federal judge has reversed course in a suit by a deaf woman who alleges she was discriminated against when Henry Ford Health System denied her an interpreter, saying she'd been mistaken in a prior order when she only considered if compensatory emotional distress damages were available under federal law.
-
July 26, 2024
Fired Doc Can Pursue Claims Against Atty Over Award Error
A Michigan state appeals court has ruled a doctor may pursue malpractice claims against the attorney who represented him during arbitration proceedings in an underlying wrongful termination suit after she allegedly failed to catch the arbitrator's miscalculation of the award, reportedly resulting in a $2.5 million loss.
-
July 26, 2024
Healthcare Software Co. Must Face Trimmed Data Hack Suit
NextGen Healthcare will face a slimmed-down version of a proposed class action filed against it by customers who say their data was exposed in a 2023 data hack after a Georgia federal judge on Thursday tossed several state data privacy and consumer protection claims levied against the software company.
-
July 26, 2024
Data Co. Told To Turn Over Contracts In Kochava Case
A D.C. federal judge plans to order TargetSmart to turn over supplier contracts to the Federal Trade Commission in the agency's case against TargetSmart client Kochava on Friday, after TargetSmart's attorney said she was "99% sure that there was no due diligence done by Kochava" regarding the data's provenance.
-
July 26, 2024
Indivior To Pay $86M To Settle Opioid Claims By 5 States
Indivior will pay $86 million to settle claims by a group of state attorneys general over the drugmaker's alleged contributions to the American opioid crisis.
-
July 26, 2024
Health Worker Says Home Insurer Must Cover Privacy Row
A woman accused of unlawfully accessing confidential patient information and disseminating it to others while working for the Yale New Haven Health System told a Connecticut federal court that her homeowner insurer owes coverage for the lawsuit, noting her policies define "personal injury" to include "invasion of privacy."
-
July 26, 2024
Hospital Can't Shift Shooting Liability To ER Group
A Michigan appellate panel has affirmed that Trinity Health Corp. can't make an emergency-room physicians practice defend it against lawsuits stemming from a shooting outside a Chicago hospital that killed one of the practice's ER doctors.
-
July 26, 2024
9th Circ. Says Online Posts Can Count As Work Harassment
The Ninth Circuit breathed new life into a psychologist's suit alleging the Federal Bureau of Prisons failed to stop a correctional officer from creating sexist and threatening social media posts about her, ruling a lower court erroneously determined the online content didn't amount to workplace harassment.
-
July 26, 2024
Rising Star: Goodwin's Peter Hanoian
Peter G. Hanoian of Goodwin Procter LLP advised Webster Equity Partners on the formation of Retina Consultants of America and its initial financing and acquisition of five specialty practices for about $350 million, earning him a spot among the healthcare law practitioners under age 40 honored by Law360 as Rising Stars.
-
July 25, 2024
3rd Circ. Again Tosses J&J Talc Unit's 'Texas Two-Step' Ch. 11
The Third Circuit on Thursday affirmed the dismissal of the reworked Chapter 11 case of Johnson & Johnson's talc unit that used a controversial "Texas two-step" maneuver, saying the company still hasn't displayed the financial distress required to justify bankruptcy protection.
Expert Analysis
-
Exploring An Alternative Model Of Litigation Finance
A new model of litigation finance, most aptly described as insurance-backed litigation funding, differs from traditional funding in two key ways, and the process of securing it involves three primary steps, say Bob Koneck, Christopher Le Neve Foster and Richard Butters at Atlantic Global Risk LLC.
-
FTC Noncompete Rule's Impact On Healthcare Nonprofits
Healthcare entities that are nonprofit or tax-exempt and thus outside of the pending Federal Trade Commission noncompete rule's reach should evaluate a number of potential risk factors and impacts, starting by assessing their own status, say Ben Shook and Tania Archer at Moore & Van Allen.
-
Cell Therapy Cos. Must Beware Limits Of Patent Safe Harbors
Though developers of gene and cell therapy products commonly assume that a legal safe harbor protects them from patent infringement suits, recent case law shows that not all preapproval uses of patented technology are necessarily protected, say Natasha Daughtrey and Joshua Weinger at Goodwin.
-
Series
Teaching Yoga Makes Me A Better Lawyer
Being a yoga instructor has helped me develop my confidence and authenticity, as well as stress management and people skills — all of which have crossed over into my career as an attorney, says Laura Gongaware at Clyde & Co.
-
How Clinical Trials Affect Patentability In US And Europe
A comparison of recent U.S. and European patent decisions — concerning the effect of disclosures in clinical trials on the patentability of products — offers guidance on good practice for companies dealing with public use issues and prior art documents in these commercially important jurisdictions, say lawyers at Finnegan.
-
Opinion
State-Regulated Cannabis Can Thrive Without Section 280E
Marijauna's reclassification as a Schedule III-controlled substance comes at a critical juncture, as removing marijuana from being subjected to Section 280E of the Internal Revenue Code is the only path forward for the state-regulated cannabis industry to survive and thrive, say Andrew Kline at Perkins Coie and Sammy Markland at FTI Consulting.
-
Key Takeaways From FDA Final Rule On Lab-Developed Tests
Michele Buenafe and Dennis Gucciardo at Morgan Lewis discuss potential consequences of the U.S. Food and Drug Administration's recently finalized rule regulating lab-developed tests as medical devices, and explain the rule's phaseout policy for enforcement discretion.
-
Examining Illinois Genetic Privacy Law Amid Deluge Of Claims
After a federal court certified an Illinois Genetic Information Privacy Act class action in August, claims under the law have skyrocketed, so employers, insurers and others that collect health and genetic information should ensure compliance with the act to limit litigation risk, say attorneys at Squire Patton.
-
Assessing HHS' Stance On Rare Disease Patient Assistance
The U.S. Department of Health and Human Services' recent advisory opinion, temporarily blessing manufacturer-supported copay funds for rare disease patients, carves a narrow path for single-donor funds, but charities and their donors may require additional assistance to navigate programs for such patients, says Mary Kohler at Kohler Health Law.
-
Opinion
Feds' Biotech Enforcement Efforts Are Too Heavy-Handed
The U.S. Department of Justice's recent actions against biotech companies untether the Anti-Kickback Statute from its original legislative purpose, and threaten to stifle innovation and undermine patient quality of care, say attorneys at Ropes & Gray.
-
Del. Ruling Highlights M&A Deal Adviser Conflict Disclosures
The Delaware Supreme Court recently reversed the Court of Chancery's dismissal of challenges to Nordic Capital's acquisition of Inovalon, demonstrating the importance of full disclosure of financial adviser conflicts when a going-private merger seeks business judgment rule review, say attorneys at Debevoise.
-
Action Steps To Address New Restrictions On Outbound Data
Companies should immediately assess all their data-based operations so they can consider strategies to effectively mitigate new compliance risks brought on by recently implemented transaction restrictions, including a Justice Department proposal and landmark data legislation, say attorneys at Wiley.
-
E-Discovery Quarterly: Recent Rulings On Text Message Data
Electronically stored information on cellphones, and in particular text messages, can present unique litigation challenges, and recent court decisions demonstrate that counsel must carefully balance what data should be preserved, collected, reviewed and produced, say attorneys at Sidley.
-
What CRA Deadline Means For Biden Admin. Rulemaking
With the 2024 election rapidly approaching, the Biden administration must race to finalize proposed agency actions within the next few weeks, or be exposed to the chance that the following Congress will overturn the rules under the Congressional Review Act, say attorneys at Covington.
-
Are Concessions In FDA's Lab-Developed Tests Rule Enough?
Although the U.S. Food and Drug Administration's new policy for laboratory-developed tests included major strategic concessions to help balance patient safety, access and diagnostic innovation, the new rule may well face significant legal challenges in court, say Dominick DiSabatino and Audrey Mercer at Sheppard Mullin.